Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
14.01
+0.41 (3.01%)
Mar 6, 2026, 2:47 PM EST - Market open
Omada Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Omada Health stock have an average target of 23.4, with a low estimate of 17 and a high estimate of 30. The average target predicts an increase of 67.02% from the current stock price of 14.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Omada Health stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $28 → $22 | Strong Buy | Maintains | $28 → $22 | +57.03% | Mar 6, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $27 → $18 | Buy | Maintains | $27 → $18 | +28.48% | Mar 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +114.13% | Mar 6, 2026 |
| Barclays | Barclays | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +28.48% | Mar 6, 2026 |
| Barclays | Barclays | Buy Maintains $22 → $17 | Buy | Maintains | $22 → $17 | +21.34% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
317.64M
from 260.21M
Increased by 22.07%
Revenue Next Year
380.38M
from 317.64M
Increased by 19.75%
EPS This Year
-0.07
from -0.35
EPS Next Year
0.21
from -0.07
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 338.4M | 409.0M | |
| Avg | 317.6M | 380.4M | |
| Low | 293.7M | 353.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.1% | 28.7% | |
| Avg | 22.1% | 19.8% | |
| Low | 12.9% | 11.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.16 | 0.44 | |
| Avg | -0.07 | 0.21 | |
| Low | -0.31 | -0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.